Yuri Peterson to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications Yuri Peterson has written about Histone Deacetylase Inhibitors.
Connection Strength
0.566
-
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity. J Med Chem. 2020 05 28; 63(10):5501-5525.
Score: 0.164
-
Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. J Med Chem. 2018 03 22; 61(6):2589-2603.
Score: 0.141
-
Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs. ACS Chem Biol. 2017 06 16; 12(6):1644-1655.
Score: 0.133
-
Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia. J Med Chem. 2016 11 10; 59(21):9942-9959.
Score: 0.128